“…In particular, with molecular-targeted drugs widely used, adverse effects of such treatments including acneiform eruptions, paronychia, xerosis, mucositis, and alopecia are thought to be less severe, but can still be significant (6). Not only can these toxicities severely affect patients' QOL, but in some specific instances, they can be associated with increased response to therapy (7). Therefore, it is of paramount importance that clinicians familiarize themselves with the basic management of the adverse effects caused by these drugs.…”